Individualised management of malignant pleural effusion

被引：26

作者：

Clive, Amelia O. ^{[1
]}

Bhatnagar, Rahul ^{[1
]}

Psallidas, Ioannis ^{[2
]}

Maskell, Nick A. ^{[1
]}

机构：

[1] Univ Bristol, Southmead Hosp, Sch Clin Sci, Acad Resp Unit, Bristol BS10 5NB, Avon, England

[2] Oxford Univ Hosp, Oxford Ctr Resp Med, Oxford Resp Trials Unit, Oxford, England

来源：

LANCET RESPIRATORY MEDICINE | 2015年 / 3卷 / 07期

关键词：

PROGNOSTIC-FACTORS; MESOTHELIOMA; PLEURODESIS; SURVIVAL; CANCER; MANOMETRY; TRIAL;

D O I：

10.1016/S2213-2600(15)00183-6

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：505 / 506

页数：2

共 15 条

[1] Prognostic Factors in Patients Presenting with Pleural Effusion Revealing Malignancy [J].

Anevlavis, Stavros ;

Kouliatsis, George ;

Sotiriou, Ioannis ;

Koukourakis, Michael I. ;

Archontogeorgis, Kostas ;

Karpathiou, Georgia ;

Giatromanolaki, Alexandra ;

Froudarakis, Marios E. .

RESPIRATION, 2014, 87 (04) :311-316

[2] Prognostic significance of pleural fluid data in patients with malignant effusion [J].

Bielsa, Silvia ;

Salud, Antonieta ;

Martinez, Montserrat ;

Esquerda, Aureli ;

Martin, Antonio ;

Rodriguez-Panadero, Francisco ;

Porcel, Jose M. .

EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (05) :334-339

[3] Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score [J].

Clive, Amelia O. ;

Kahan, Brennan C. ;

Hooper, Clare E. ;

Bhatnagar, Rahul ;

Morley, Anna J. ;

Zahan-Evans, Natalie ;

Bintcliffe, Oliver J. ;

Boshuizen, Rogier C. ;

Fysh, Edward T. H. ;

Tobin, Claire L. ;

Medford, Andrew R. L. ;

Harvey, John E. ;

van den Heuvel, Michel M. ;

Lee, Y. C. Gary ;

Maskell, Nick A. .

THORAX, 2014, 69 (12) :1098-1104

[4] Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience [J].

Curran, D ;

Sahmoud, T ;

Therasse, P ;

van Meerbeeck, J ;

Postmus, PE ;

Giaccone, G .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :145-152

[5] Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion The TIME2 Randomized Controlled Trial [J].

Davies, Helen E. ;

Mishra, Eleanor K. ;

Kahan, Brennan C. ;

Wrightson, John M. ;

Stanton, Andrew E. ;

Guhan, Anur ;

Davies, Christopher W. H. ;

Grayez, Jamal ;

Harrison, Richard ;

Prasad, Anjani ;

Crosthwaite, Nicola ;

Lee, Y. C. Gary ;

Davies, Robert J. O. ;

Miller, Robert F. ;

Rahman, Najib M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22) :2383-2389

[6] Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion [J].

Dresler, CM ;

Olak, J ;

Herndon, JE ;

Richards, WG ;

Scalzetti, E ;

Fleishman, SB ;

Kernstine, KH ;

Demmy, T ;

Jablons, DM ;

Kohman, L ;

Daniel, TM ;

Haasler, GB ;

Sugarbaker, DJ .

CHEST, 2005, 127 (03) :909-915

[7] Point: Should Pleural Manometry Be Performed Routinely During Thoracentesis? Yes [J].

Feller-Kopman, David .

CHEST, 2012, 141 (04) :844-845

[8] Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B [J].

Herndon, JE ;

Green, MR ;

Chahinian, AP ;

Corson, JM ;

Suzuki, Y ;

Vogelzang, NJ .

CHEST, 1998, 113 (03) :723-731

[9]

LEAHY BC, 1985, EUR J RESPIR DIS, V66, P50

[10] Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales [J].

Linton, A. ;

Pavlakis, N. ;

O'Connell, R. ;

Soeberg, M. ;

Kao, S. ;

Clarke, S. ;

Vardy, J. ;

van Zandwijk, N. .

BRITISH JOURNAL OF CANCER, 2014, 111 (09) :1860-1869

← 1 2 →